A Dose Escalation Study of PF-06650808 in Patients With Advanced Solid Tumors

NCT02129205 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
40
Enrollment
INDUSTRY
Sponsor class

Stopped The study was terminated due to a change in sponsor prioritization.

Conditions

Interventions

Sponsor

Pfizer